Cystathionine ␥-lyase (CSE) is the major enzyme in vascular smooth muscle cells (SMCs) that catalyzes the endogenous production of H 2 S. Phenotypic switching of SMCs is affected by endogenous H 2 S level and alterations of this switching may result in vascular disorders. To date, the mechanisms underlying the alteration of CSE expression and H 2 S production in vascular proliferative diseases have been unclear. In the present study, we found that serum deprivation induced SMC differentiation marker gene expressions and increased CSE expression and H 2 S production in cultured human aorta SMCs (HASMCs). Carotid artery ligation in mice resulted in enhanced neointima formation and down-regulation of CSE expression, suggesting an important role of CSE in SMC differentiation. Transient transfection of HASMCs with human CSE (hCSE) promoter/ luciferase reporter revealed that the region between ؊226 to ؉140 base pair contains the core promoter for the hCSE gene. Deletion and mutation analysis demonstrated that two specificity protein-1 (Sp1) consensus binding sites were present in the core promoter region of the hCSE gene. Incubation of HASMCs with Sp1 binding inhibitor mithramycin inhibited CSE mRNA expression in a dose-dependent manner. Overexpression of Sp1 alone was sufficient to increase the activity of the hCSE core promoter and CSE protein expression. Chromatin immunoprecipitation assay showed that the binding of Sp1 to the hCSE promoter was increased in differentiated HASMCs compared with that in proliferated HASMCs. Exogenously applied H 2 S at 100 M stimulated SMC differentiation, which was reversed by p38 MAPK inhibitor SB203580. These results suggest that transcript factor Sp1 is a critical regulator of the hCSE expression during SMC differentiation, and CSE/H 2 S system is essential for maintenance of SMC phenotype.
Vascular smooth muscle cells (SMCs)2 are highly specialized cells whose contractile status regulates blood vessel tone, blood pressure, and blood flow (1, 2). Vascular SMCs can alternate their phenotypes from contractile (differentiated) to synthetic (proliferated) phenotypes in response to extracellular cues (1-3). Concomitant with this phenotypic change, a variety of SMC differentiation-specific genes, including SM myosin heavy chain (SM-MHC), calponin, SM22␣, SM ␣-actin, and smoothelin, are reduced (4, 5). SMC phenotypic switching is believed to play a key role in many cardiovascular diseases, such as hypertension, atherosclerosis, coronary heart diseases, postangioplasty restenosis, and transplantation arteriopathy (4, 6, 7).In recent years, hydrogen sulfide (H 2 S) has emerged as a novel and important gasotransmitter for the cardiovascular system (8 -10). CSE is the major H 2 S-producing enzyme in vascular tissues, and abnormal metabolism and functions of the CSE/H 2 S pathway have been linked to various cardiovascular diseases, including atherosclerosis and hypertension (9, 11, 12). CSE expression and H 2 S production were reduced during the development of atherosclerotic plaque in apolip...